Kerry Wentworth
Chief Regulatory Officer at Nuvation Bio Inc. (NUVB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 24SEC | NUVBNuvation Bio Inc. | Sell Plan | 63,00053,000 held (−54%) | $6.02 | $379K | -26.1% |
| Apr 21SEC | NUVBNuvation Bio Inc. | Sell Plan | 36,75053,000 held (−41%) | $5.01 | $184K | -11.2% |
| Apr 8SEC | NUVBNuvation Bio Inc. | Sell Plan | 200,00053,000 held (−79%) | $4.52 | $904K | -1.5% |
- Sell
Chief Regulatory Officer Kerry Wentworth sold $379K of NUVB at $6.02 — cuts the stake by 54%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Regulatory Officer Kerry Wentworth sold $184K of NUVB at $5.01 — cuts the stake by 41%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Regulatory Officer Kerry Wentworth sold $904K of NUVB at $4.52 — cuts the stake by 79%; pre-scheduled 10b5-1 plan sale.